Stay updated with breaking news from Stroke Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published today in the American Stroke Association's journal Stroke.
Dr. Nicholas Larochelle, M.D., Medical Director of Emergency Medicine, the Transfer Center, and the Stroke Program for the Concord Hospital health system discusses stroke symptoms, treatment, and prevention. What are the symptomsof a stroke?Stroke is...
~30% relative risk reduction seen in symptomatic ischemic strokes in three milvexian arms compared to placebo; dose response not observed for primary study objective No fatal bleeding and no increase
28.08.2022 - Bristol Myers Squibb (NYSE:BMY) in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), today announced results from the Phase 2 AXIOMATIC-SSP dose-ranging study of the ...